다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Tyra Biosciences Inc (TYRA)
Tyra Biosciences Inc (TYRA) 뉴스

TYRA

Tyra Biosciences (TYRA)

Tyra Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TYRA

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	05:05	PR Newswire (US)	Tyra Biosciences to Present at Upcoming Investor Conferences	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/10	05:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/10	05:46	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/10	05:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/10	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/10	05:05	PR Newswire (US)	Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/08	05:34	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/08	05:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TYRA	Tyra Biosciences Inc
2024/05/08	05:05	PR Newswire (US)	Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors	NASDAQ:TYRA	Tyra Biosciences Inc
2024/03/20	05:05	PR Newswire (US)	Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights	NASDAQ:TYRA	Tyra Biosciences Inc
2024/03/09	07:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/03/06	07:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/03/01	08:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/28	06:05	PR Newswire (US)	Tyra Biosciences to Present at Upcoming Investor Conferences	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/15	11:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/14	06:36	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/13	06:46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/10	09:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/08	06:05	PR Newswire (US)	Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/07	10:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/07	06:56	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/05	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/03	07:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/02	22:00	PR Newswire (US)	Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/02	07:30	PR Newswire (US)	Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia	NASDAQ:TYRA	Tyra Biosciences Inc
2024/02/02	07:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TYRA	Tyra Biosciences Inc
2023/12/22	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TYRA	Tyra Biosciences Inc
2023/12/22	23:00	PR Newswire (US)	Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300	NASDAQ:TYRA	Tyra Biosciences Inc
2023/11/09	06:05	PR Newswire (US)	Tyra Biosciences to Participate in 2023 Jefferies London Healthcare Conference	NASDAQ:TYRA	Tyra Biosciences Inc
2023/11/08	06:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TYRA	Tyra Biosciences Inc

검색 관련기사 보기:NASDAQ:TYRA

1 2 3 4 5 다음 >>

Deutsche Telekom (QX)

Health Care Select Sector

American Express

US Dollar vs Euro

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

US Dollar vs Yen

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관